High-Sensitivity Cardiac Troponin and Primary Prevention: An Important New Role

J Am Coll Cardiol. 2016 Dec 27;68(25):2729-2732. doi: 10.1016/j.jacc.2016.11.006.

Authors

Allan S Jaffe¹, R Scott Wright²

Affiliations

¹ Department of Cardiology, Mayo Clinic, Rochester, Minnesota; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota. Electronic address: jaffe.allan@mayo.edu.
² Department of Cardiology, Mayo Clinic, Rochester, Minnesota.

PMID: 28007134
DOI: 10.1016/j.jacc.2016.11.006

No abstract available

Keywords: HMG-CoA reductase inhibitors; cardiac troponin; cardiovascular disease; myocyte toxicity; primary prevention.

Publication types

Editorial
Comment

MeSH terms

Biomarkers
Primary Prevention*
Troponin I
Troponin T
Troponin*

Substances

Biomarkers
Troponin
Troponin I
Troponin T